← Back to Search

MyPADMGT for Peripheral Arterial Disease (Final_PADHSS Trial)

N/A
Waitlist Available
Led By Michael Stacey, MD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Final_PADHSS Trial Summary

This trial will test an online program to help people with peripheral arterial disease and high blood pressure to better self-manage their condition.

Eligible Conditions
  • Peripheral Arterial Disease

Final_PADHSS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
EQ-5D-5L Quality of Life Visual Result
Systolic Blood Pressure
Secondary outcome measures
Ankle Brachial Index
Body Weight
Smoking Cessation
+1 more

Final_PADHSS Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: MyPADMGT + NudgingExperimental Treatment1 Intervention
Online access to system, with ability to record and study progress with social interaction, diet, physical activity, smoking cessation, blood glucose, blood pressure and weight. Also access to educational content, journal recording, communication to others, setting target levels, contact support as needed. In addition, nudging support available to help patients make better choices and decisions.
Group II: MyPADMGTExperimental Treatment1 Intervention
Online access to system, with ability to record and study progress with social interaction, diet, physical activity, smoking cessation, blood glucose, blood pressure and weight. Also access to educational content, journal recording, communication to others, setting target levels, contact support as needed.
Group III: ControlActive Control1 Intervention
Usual care

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
891 Previous Clinical Trials
2,605,340 Total Patients Enrolled
2 Trials studying Peripheral Arterial Disease
200 Patients Enrolled for Peripheral Arterial Disease
Michael Stacey, MDPrincipal InvestigatorMcMaster University
~30 spots leftby Jun 2025